Abstract
The family of G-protein-coupled receptors (GPCRs) is by far the best-studied family among the integral membrane proteins, because it represents the largest and most important group for therapeutics. In this chapter we provide an overview of the major developments in the GPCR field since the 19th century, and we shed some light on some of the questions that are relevant now and those that need to be answered in the future regarding GPCR structure and function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benovic JL, Kühn H, Weyand I, Codina J, Caron MG, Lefkowitz J (1987) Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 84: 8879–8882
Bond R and Ijzerman AP (2006) Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 27: 92–96
Bond R, Leff P, Johnson TD, Milano CA, Rockman HA, McMinn TR, Apparsundaram S, Hyek MF, Kenakin TP, Allen LF (1995) Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature 374: 272–276
Brézillon S, Detheux M, Parmentier M, Hökfelt T, Hurd YL (2001) Distribution of an orphan G-protein coupled receptor (JP05) mRNA in the human brain. Brain Res 921: 21–30
Brézillon S, Lannoy V, Franssen J, Le Poul E, Dupriez V, Lucchetti J, Detheux M, Parmentier M (2003) Identification of natural ligands for the orphan G-protein-coupled receptors GPR7 and GPR8. J Biol Chem 278: 776–783
Bywater RP (2005) Location and nature of the residues important for ligand recognition in G-protein coupled receptors. J Mol Recognit 18: 60–72
Caron MG, Srinivasan Y, Pitha J, Kociolek K, Lefkowitz RJ (1979) Affinity chromatography of the beta-adrenergic receptor. J Biol Chem 254: 2923–2927
Cerione R, Strulovici B, Benovic JL, Strader CD, Caron MG, Lefkowitz RJ (1983) Reconstitution of beta-adrenergic receptors in lipid vesicles: affinity chromatography-purified receptors confer catecholamine responsiveness on a heterologous adenylate cyclase system. Proc Natl Acad Sci USA 80: 4899–4903
Cerione R, Sibley DR, Codina J, Benovic JL, Winslow J, Neer EJ, Birnbaumer L, Caron MG, Lefkowitz RJ (1984) Reconstitution of a hormone-sensitive adenylate cyclase system. The pure beta-adrenergic receptor and guanine nucleotide regulatory protein confer hormone responsiveness on the resolved catalytic unit. J Biol Chem 259: 9979–9982
Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Tian FS, Kobilka TS, Choi H, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G-protein-coupled receptor. Science 318: 1258–1265
Conn PM, Rogers DC, McNeil R (1982a) Potency enhancement of a GnRH agonist: GnRH-receptor microaggregation stimulates gonadotropin release. Endocrinology 111: 335–337
Conn PM, Rogers DC, Stewart JM, Niedel J, Shefield T (1982b) Conversion of a gonadotropin-releasing hormone antagonist to an agonist. Nature 296: 653–655
Conn PJ, Christopoulos A, Lindsley CW (2009) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 8: 41–54
Costa T and Herz A (1989) Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86: 7321–7325
Costa T, Ogino Y, Munson PJ, Onaran HO, Rodbard D (1992) Drug efficacy at guanine nucleotidebinding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol41: 549–560
Cotecchia S, Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ (1992) Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem 267: 1633–1639
Dahl SG, Edvardsen O, Sylte I (1991) Molecular dynamics of dopamine at the D2 receptor. Proc Natl Acad Sci USA 88: 8111–8115
De Lean A, Stadel JM, Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255: 7108–7117
Dean MK, Higgs C, Smith RE, Bywater RP, Snell CR, Scot PD, Upton GJ, Howe TJ, Reynolds CA (2001) Dimerization of G-protein-coupled receptors. J Med Chem 44: 4595–4614
Dixon R, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE, Mumford R, Slater EE, Sigal IS, Caron MG, Lefkowitz RJ, Strader CD (1986) Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321: 75–79
Donnelly D and Findlay JB (1994) Seven-helix receptors: structure and modelling. Curr Opin Struct Biol 4: 582–589
Fanelli F, Menziani C, Scheer A, Cotecchia S, De Benedetti PG (1999) Theoretical study of the electrostatically driven step of receptor-G-protein recognition. Proteins 37: 145–156
Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ (1988) The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335: 358–360
Farrens DL, Altenbach C, Yang K, Hubbell WL, Khorana HG (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274: 768–770
Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, Palczewski K (2003) Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421: 127–128
van Galen PJ, van Bergen AH, Gallo-Rodriguez C, Melman N, Olah ME, Ijzerman A P, Stiles GL, Jacobson KA (1994) A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol45: 1101–1111
Gilman AG (1987) G-proteins: transducers of receptor-generated signals. Ann Rev Biochem 56: 615–649
Hamm HE (1998) The many faces of G-protein signaling. J Biol Chem 273: 669–672
Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola V, Chien EYT, Velasquez J, Kuhn P, Stevens RC (2008) A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure 16: 897–905
Hanyaloglu AC and von Zastrow M (2008) Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Ann Rev Pharmacol Toxicol 48: 537–568
Hargrave PA, McDowell JH, Curtis DR, Wang JK, Juszczak E, Fong SL, Rao JK, Argos P (1983) The structure of bovine rhodopsin. Biophys Struct Mech 9: 235–244
Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271: 16384–16392
Henderson R and Unwin PN (1975) Three-dimensional model of purple membrane obtained by electron microscopy. Nature 257: 28–32
Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH (1990) Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol 213: 899–929
Hébert TE and Bouvier M (1998) Structural and functional aspects of G-protein-coupled receptor oligomerization. Biochem Cell Biol 76: 1–11
Hibert MF, Trumpp-Kallmeyer S, Bruinvels A, Hoflack J (1991) Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol Pharmacol 40: 8–15
Horn F, Bywater R, Krause G, Kuipers W, Oliveira L, Paiva AC, Sander C, Vriend G (1998) The interaction of class B G-protein-coupled receptors with their hormones. Receptors Channels 5: 305–314
Horn F, Bettler E, Oliveira L, Campagne F, Cohen FE, Vriend G (2003) GPCRDB information system for G-protein-coupled receptors. Nucleic Acids Res 31: 294–297
Hornak V, Ahuja S, Eilers M, Goncalves JA, Sheves M, Reeves PJ, Smith SO (2010) Light activation of rhodopsin: insights from molecular dynamics simulations guided by solid-state NMR distance restraints. J Mol Biol 396(3): 510–527
Howard MJ, Hughes RJ, Motulsky HJ, Mullen MD, Insel PA (1987) Interactions of amiloride with alpha-and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors. Mol Pharmacol 32: 53–58
Jaakola V, Griffith MT, Hanson MA, Cherezov V, Chien EYT, Lane JR, Ijzerman A P, Stevens RC (2008) The 2.6 Angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322: 1211–1217
Katritch V, Reynolds K, Cherezov V, Hanson MA, Roth CB, Yeager M, Abagyan R (2009) Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. J Mol Recognit 22: 307–318
Kenakin T (2001) Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J 15: 598–611
Kenakin T (2002) Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 1: 103–110
Kent RS, De Lean A, Lefkowitz RJ (1980) A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol Pharmacol 17: 14–23
Kim J, Jiang Q, Glashofer M, Yehle S, Wess J, Jacobson K (1996) Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition. Mol Pharmacol 49: 683–691
Kim J, Altenbach C, Kono M, Oprian DD, Hubbell WL, Khorana HG (2004) Structural origins of constitutive activation in rhodopsin: role of the K296/E113 salt bridge. Proc Natl Acad Sci USA 101: 12508–12513
Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ (1992) Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267: 1430–1433
Kobilka BK and Deupi X (2007) Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28: 397–406
Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, Lefkowitz RJ, Caron MG (1987a) An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329: 75–79
Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon R, Keller P, Caron MG, Lefkowitz RJ (1987b) Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem 262: 7321–7327
Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW (1987c) Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science 238: 650–656
Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ (2009) Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 17: 443–458
Langley JN (1905) On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol 33: 374–413
Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14: 303–307
Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, Maenhaut C, Simons MJ, Dumont JE, Vassart G (1989) Selective amplification and cloning of four new members of the G-protein-coupled receptor family. Science 244: 569–572
Libert F, Vassart G, Parmentier M (1991) Current developments in G-protein-coupled receptors. Curr Opin Cell Biol 3: 218–223
Limbird LE, Meyts PD, Lefkowitz RJ (1975) Beta-adrenergic receptors: evidence for negative cooperativity. Biochem Biophys Res Commun 64: 1160–1168
Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 248: 1547–1550
Maehle A (2004) “Receptive substances”: John Newport Langley (1852–1925) and his path to a receptor theory of drug action. Med Hist 48: 153–174
May DC, Ross EM, Gilman AG, Smigel MD (1985) Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins. J Biol Chem 260: 15829–15833
Mickey J, Tate R, Lefkowitz RJ (1975) Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro. J Biol Chem 250: 5727–5729
Mills A and Duggan MJ (1994) Orphan seven transmembrane domain receptors: reversing pharmacology. Trends Biotechnol 12: 47–49
Mukherjee C, Caron MG, Coverstone M, Lefkowitz RJ (1975) Identification of adenylate cyclase-coupled beta-adrenergic receptors in frog erythrocytes with (minus)-[3-H] alprenolol. J Biol Chem 250: 4869–4876
Oliveira L, Paiva AC, Sander C, Vriend G (1994) A common step for signal transduction in G-proteincoupled receptors. Trends Pharmacol Sci 15: 170–172
Oliveira L, Paiva AC, Vriend G (1999) A low resolution model for the interaction of G-proteins with G-protein-coupled receptors. Protein Eng 12: 1087–1095
Oliveira L, Hulsen T, Lutje Hulsik D, Paiva ACM, Vriend G (2004) Heavier-than-air flying machines are impossible. FEBS Lett 564: 269–273
Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ (1992) Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. Ann Rev Pharmacol Toxicol 32: 167–183
Ovchinnikov YuA (1982) Rhodopsin and bacteriorhodopsin: structure-function relationships. FEBS Lett 148: 179–191
Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5: 993–996
Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Crystal structure of rhodopsin: a G-protein-coupled receptor. Science 289: 739–745
Pardo L, Ballesteros JA, Osman R, Weinstein H (1992) On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. Proc Natl Acad Sci USA 89: 4009–4012
Parmentier M and Detheux M (2006) Deorphanization of G-protein-coupled receptors. Ernst Schering Found Symp Proc 2: 163–186
Pepitoni S, Wood IC, Buckley NJ (1997) Structure of the m1 muscarinic acetylcholine receptor gene and its promoter. J Biol Chem 272: 17112–17117
Pert CB and Snyder SH (1973) Opiate receptor: demonstration in nervous tissue. Science 179: 1011–1014
Pitcher JA, Freedman NJ, Lefkowitz RJ (1998) G-protein-coupled receptor kinases. Ann Rev Biochem 67: 653–692
Rall TW and Sutherland EW (1958) Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 232: 1065–1076
Rasmussen SGF, Choi H, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VRP, Sanishvili R, Fischetti RF, Schertler GFX, Weis WI, Kobilka BK (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450: 383–387
Ritter SL and Hall R (2009) Fine-tuning of GPCR activity by receptor-interactinG-proteins. Nat Rev Mol Cell Biol 10: 819–830
Rodbell M, Birnbaumer L, Pohl SL, Krans HM (1971) The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J Biol Chem 246: 1877–1882
Rognan D (2006) Ligand design for G-protein-coupled receptors. Wiley-VCH
Ross EM and Gilman AG (1977) Resolution of some components of adenylate cyclase necessary for catalytic activity. J Biol Chem 252: 6966–6969
Savarese TM, Wang CD, Fraser CM (1992) Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. J Biol Chem 267: 11439–11448
Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe H, Hofmann KP, Ernst OP (2008) Crystal structure of opsin in its G-protein-interacting conformation. Nature 455: 497–502
Scholl DJ and Wells JN (2000) Serine and alanine mutagenesis of the nine native cysteine residues of the human A(1) adenosine receptor. Biochem Pharmacol 60: 1647–1654
Seifert R and Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedeberg’s Arch Pharmacol 366: 381–416
Shi L and Javitch JA (2002) The binding site of aminergic G-protein-coupled receptors: the transmembrane segments and second extracellular loop. Ann Rev Pharmacol Toxicol 42: 437–467
Shi L and Javitch JA (2004) The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc Natl Acad Sci USA 101: 440–445
Shi L, Liapakis G, Xu R, Guarnieri F, Ballesteros JA, Javitch JA (2002) Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J Biol Chem 277: 40989–40996
Stadel JM, Nambi P, Shorr RG, Sawyer DF, Caron MG, Lefkowitz RJ (1983) Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the beta-adrenergic receptor. Proc Natl Acad Sci USA 80: 3173–3177
Strader CD, Fong TM, Tota MR, Underwood D, Dixon R (1994) Structure and function of G-protein-coupled receptors. Ann Rev Biochem 63: 101–132
Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y (1990) Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347: 80–83
Sutherland EW and Rall TW (1958) Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J Biol Chem 232: 1077–1091
Tobin AB (2008) G-protein-coupled receptor phosphorylation: where, when and by whom. Br J Pharm 153(Suppl 1): S167–S176
Townsend-Nicholson A and Schofield PR (1994) A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding. J Biol Chem 269: 2373–2376
Walsh DA, Perkins JP, Krebs EG (1968) An adenosine 3′,5′-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem 243: 3763–3765
Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AGW, Tate CG, Schertler GFX (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454: 486–491
Wilden U and Kühn H (1982) Light-dependent phosphorylation of rhodopsin: number of phosphorylation sites. Biochemistry 21: 3014–3022
Wilden U, Hall SW, Kühn H (1986) Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci USA 83: 1174–1178
Wurch T and Pauwels PJ (2000) Coupling of canine serotonin 5-HT(1B) and 5-HT(1D) receptor ubtypes to the formation of inositol phosphates by dual interactions with endogenous G(i/o) and recombinant G(alpha15) proteins. J Neurochem 75: 1180–1189
Yamamura HI and Snyder SH (1974) Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71: 1725–1729
Zhao MM, Hwa J, Perez DM (1996) Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding. Mol Pharmacol 50: 1118–1126
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Vroling, B., Bywater, R.P., Oliveira, L., Vriend, G. (2010). GPCRs: Past, present, and future. In: Structural Bioinformatics of Membrane Proteins. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0045-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0045-5_14
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0044-8
Online ISBN: 978-3-7091-0045-5
eBook Packages: Computer ScienceComputer Science (R0)